N-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide

C13H14BrFN6O4S2 — CID 142341885

IUPACN-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide
SMILESN/C(=N\c1ccc(F)c(Br)c1)c1nonc1SCCNC(=O)CS(N)(=O)=O
InChIInChI=1S/C13H14BrFN6O4S2/c14-8-5-7(1-2-9(8)15)19-12(16)11-13(21-25-20-11)26-4-3-18-10(22)6-27(17,23)24/h1-2,5H,3-4,6H2,(H2,16,19)(H,18,22)(H2,17,23,24)
InChIKeyBBKQXBBJGOASSY-UHFFFAOYSA-N
MW481.33 g/mol
LogP0.50
Rot. Bonds8

About N-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide

N-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide (PubChem CID 142341885) has the molecular formula C13H14BrFN6O4S2 and a molecular weight of 481.33 g/mol. Its IUPAC name is N-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide.

Molecular Properties

Compound NameN-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide
PubChem CID142341885
Molecular FormulaC13H14BrFN6O4S2
Molecular Weight481.33 g/mol
Exact Mass479.97
IUPAC NameN-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide
SMILESN/C(=N\c1ccc(F)c(Br)c1)c1nonc1SCCNC(=O)CS(N)(=O)=O
InChIInChI=1S/C13H14BrFN6O4S2/c14-8-5-7(1-2-9(8)15)19-12(16)11-13(21-25-20-11)26-4-3-18-10(22)6-27(17,23)24/h1-2,5H,3-4,6H2,(H2,16,19)(H,18,22)(H2,17,23,24)
InChIKeyBBKQXBBJGOASSY-UHFFFAOYSA-N
XLogP0.50
TPSA166.56 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500481.33
LogP ≤ 50.50
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze N-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide?
The IUPAC name of N-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide (CID 142341885) is N-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide.
What is the SMILES notation for N-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide?
The canonical SMILES for N-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide is N/C(=N\c1ccc(F)c(Br)c1)c1nonc1SCCNC(=O)CS(N)(=O)=O.
What is the InChIKey of N-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide?
The InChIKey is BBKQXBBJGOASSY-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H14BrFN6O4S2/c14-8-5-7(1-2-9(8)15)19-12(16)11-13(21-25-20-11)26-4-3-18-10(22)6-27(17,23)24/h1-2,5H,3-4,6H2,(H2,16,19)(H,18,22)(H2,17,23,24).
What are the key properties of N-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide?
N-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide has a molecular weight of 481.33 g/mol, XLogP of 0.50, 8 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[[4-[N'-(3-bromo-4-fluorophenyl)carbamimidoyl]-1,2,5-oxadiazol-3-yl]sulfanyl]ethyl]-2-sulfamoylacetamide is sourced from PubChem (CID 142341885), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).